Kure Cells

Oslo, Norway

Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.

$10.0M raised

Oct 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Kure Cells raised?

Kure Cells has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Kure Cells's investors?

Kure Cells's investors include NantBio, Wa’ed Ventures, Qomel.

Where is Kure Cells headquartered?

Kure Cells is headquartered in Oslo, Norway.

What does Kure Cells do?

Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.

What stage is Kure Cells at?

Kure Cells is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 23, 2025.

MLA

"Kure Cells — Funding & Investors." VCBacked, October 23, 2025, https://www.vcbacked.co/company/kure-cells. Accessed July 2, 2026.

APA

VCBacked. (2025). Kure Cells — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kure-cells

Wikipedia (cite web)

{{cite web |title=Kure Cells — Funding & Investors |url=https://www.vcbacked.co/company/kure-cells |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 23, 2025.